Achieve Life Sciences, Inc. (ACHV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 6.4 |
| Open | 6.37 |
| Day High | 6.4 |
| Day Low | 5.81 |
| 52-Week High | 7.11 |
| 52-Week Low | 2.37 |
| Volume | 2.05M |
| Average Volume | 2.06M |
| Market Cap | 627.25M |
| PE | -5.46 |
| EPS | -1.12 |
| Moving Average 50 Days | 5.35 |
| Moving Average 200 Days | 4.54 |
| Change | -0.29 |
Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study
GlobeNewswire Inc.
Mar 04, 2026 1:00 PM GMT
A pooled Phase 3 analysis of more than 1,600 people who smoke showed high quit rates; including among those who had previously not succeeded with other smoking cessation medications and regardless of the number of prior quit attempts Late-breaking s
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer
GlobeNewswire Inc.
Jan 12, 2026 1:47 PM GMT
Experienced medical executive advances to permanent role following successful leadership as Interim CMOSEATTLE and VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pha
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
GlobeNewswire Inc.
Dec 08, 2025 9:10 PM GMT
SEATTLE and VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treat